Figure 1.
Figure 1. Survival with mini-hyper-CVD+IO vs hyper-CVAD +/- rituximab in frontline ALL

Survival with mini-hyper-CVD+IO vs hyper-CVAD +/- rituximab in frontline ALL

Close Modal

or Create an Account

Close Modal
Close Modal